Press Tag: Clarametyx Biosciences

Categories
CincyTech Invests in Clarametyx to Advance Breakthrough Anti-Biofilm Therapies for Chronic Respiratory Disease
Company News, Funding News
CincyTech Invests in Clarametyx to Advance Breakthrough Anti-Biofilm Therapies for Chronic Respiratory Disease
Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections
Company News
Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections
Clarametyx Bioscience Recognized as “Infectious Disease Innovation of the Year” In 2024 BioTech Breakthrough Awards
Company News
Clarametyx Bioscience Recognized as “Infectious Disease Innovation of the Year” In 2024 BioTech Breakthrough Awards
Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients
Company News
Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients
Top Tech Companies In Ohio To Watch in 2025
Company News, Rev1 News
Top Tech Companies In Ohio To Watch in 2025
Nationwide Children’s infection-busting treatment gets pivotal tests
Nationwide Children’s infection-busting treatment gets pivotal tests
Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections
Funding News
Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections
Clarametyx Announces Positive Early Phase 1 Safety Findings on CMTX-101, Immune-Enabling Antibody Therapy
Clarametyx Announces Positive Early Phase 1 Safety Findings on CMTX-101, Immune-Enabling Antibody Therapy
Startups to Watch: These Central Ohio Companies Could Take Off in 2023
Company News
Startups to Watch: These Central Ohio Companies Could Take Off in 2023
1 2